Toward Rapid, Widely Available Autologous CAR-T Cell Therapy – Artificial Intelligence and Automation Enabling the Smart Manufacturing Hospital

CAR-T cell therapy is a promising treatment for acute leukemia and lymphoma. CAR-T cell therapies take a pioneering role in autologous gene therapy with three EMA-approved products. However, the chance of clinical success remains relatively low as the applicability of CAR-T cell therapy suffers from...

Descripción completa

Detalles Bibliográficos
Autores principales: Hort, Simon, Herbst, Laura, Bäckel, Niklas, Erkens, Frederik, Niessing, Bastian, Frye, Maik, König, Niels, Papantoniou, Ioannis, Hudecek, Michael, Jacobs, John J. L., Schmitt, Robert H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207622/
https://www.ncbi.nlm.nih.gov/pubmed/35733863
http://dx.doi.org/10.3389/fmed.2022.913287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207622/
https://www.ncbi.nlm.nih.gov/pubmed/35733863
http://dx.doi.org/10.3389/fmed.2022.913287

Ejemplares similares